✨ Consent to Distribution of New Medicines




NEW ZEALAND GAZETTE, No. 34 β€” 21 APRIL 2016

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ipca-Allopurinol
Allopurinol 100mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Ipca-Allopurinol
Allopurinol 300mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Xandane
Allopurinol 100mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Xandane
Allopurinol 300mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India

Dated this 15th day of April 2016.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

2016-go2198

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Albey Bee Venom
Bee venom 550mcg
Powder for injection with diluent
Ebos Group Limited
Jubilant Hollister-Stier LLC, Washington, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Albey Paper Wasp Venom
Wasp venom protein 550mcg
Powder for injection with diluent
Ebos Group Limited
Jubilant Hollister-Stier LLC, Washington, United States of America

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Albey Yellow Jacket Venom
Wasp venom protein 550mcg
Powder for injection with diluent
Ebos Group Limited
Jubilant Hollister-Stier LLC, Washington, United States of America

Product:
Active Ingredients:

  • Influenza virus A/California/7/2009 (H1N1) like strain 15mcg
  • Influenza virus A/Texas/50/2012 (H3N2) like strain 15mcg
  • Influenza virus B/Massachusetts/2/2012 like strain 15mcg
  • Influenza virus B/Yamagata 16/88 15mcg
    Dosage Form:
    New Zealand Sponsor:
    Manufacturer:
    Fluarix Tetra
    Suspension for injection
    GlaxoSmithKline (NZ) Limited
    GlaxoSmithKline Biologicals (Dresden), Dresden, Germany


Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2016, No 34





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
15 April 2016
Medicines, Distribution, Consent, Medicines Act 1981
  • CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Medicines Act 1981